← Back to Search

Decision Aid for Thyroid Nodules

N/A
Recruiting
Led By Lukasz Czerwonka, MD
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histology showing indeterminate or malignant thyroid pathology (Bethesda III-VI)
Thyroid nodule size less or equal to 2cm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months from surgery or surgical consultation date
Awards & highlights

Study Summary

This trial is testing a new way to help people with small, cancerous, or indeterminate thyroid nodules make decisions about treatment. participants will be surveyed about their decision-making process and satisfaction with the new system.

Who is the study for?
This trial is for individuals with small thyroid nodules (2cm or smaller) that are possibly malignant or of uncertain nature, without a history of thyroid surgery or cancer. Participants will receive education on managing thyroid nodules and complete surveys to evaluate their satisfaction with the decision-making process.Check my eligibility
What is being tested?
The study focuses on providing patients with information about managing small potentially malignant or indeterminate thyroid nodules. It aims to see if this education affects patient satisfaction regarding treatment decisions after consulting with surgeons.See study design
What are the potential side effects?
Since the intervention involves educational information rather than medication, there are no direct medical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My thyroid biopsy shows uncertain or cancerous results.
Select...
My thyroid nodule is 2cm or smaller.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months from surgery or surgical consultation date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from surgery or surgical consultation date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of congruence between informed values and treatment choice

Trial Design

1Treatment groups
Experimental Treatment
Group I: Thyroid nodule informationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor
217 Previous Clinical Trials
39,852 Total Patients Enrolled
Lukasz Czerwonka, MDPrincipal InvestigatorLukasz.Czerwonka@stonybrookmedicine.edu

Media Library

Thyroid Nodule Management Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT05264857 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Have any new participants been admitted to this clinical trial recently?

"Affirmative. Supporting documents on clinicaltrials.gov demonstrate that this research effort, which was initially publicized on February 8th 2022, is still looking for participants. 134 individuals need to be recruited from 1 particular medical centre."

Answered by AI

To what extent has this clinical trial been populated with participants?

"Affirmative, the information available on clinicaltrials.gov reflects that this medical trial is actively seeking participants. The initial posting was published on February 8th 2022 and has been updated as recent as March 1st 2022. This study requires 134 patients to be recruited from a single location."

Answered by AI
~68 spots leftby Sep 2026